Received Dec 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
seizures; This spontaneous report was received from a Consumer or other non health professional and refers to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions included Taking medication for seizures (discrepancy as it was also reported that seizures started after vaccination of GARDASIL 9). Concomitant therapies were not reported. On 2015, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), (frequency: 1 injection), (dose, lot # and expiration date were not reported). On 2015, and at day 5, the patient experienced seizures and was taking medication for the condition. At the reporting time, the patient had not recovered from seizures. The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant was reported as not applicable. The causal relationship between the event of seizures and Human Papillomavirus 9-valent Vaccine, Recombinant was unknown. Upon internal review, the event of seizures was determined to be medically significant.
Seizures